These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 12458380

  • 1. Transureteroureterostomy: an adjunct to the management of advanced primary and recurrent pelvic malignancy.
    Sugarbaker PH, Gutman M, Verghese M.
    Int J Colorectal Dis; 2003 Jan; 18(1):40-4. PubMed ID: 12458380
    [Abstract] [Full Text] [Related]

  • 2. Surgical salvage of recurrent rectal cancer after transanal excision.
    Weiser MR, Landmann RG, Wong WD, Shia J, Guillem JG, Temple LK, Minsky BD, Cohen AM, Paty PB.
    Dis Colon Rectum; 2005 Jun; 48(6):1169-75. PubMed ID: 15793645
    [Abstract] [Full Text] [Related]

  • 3. Radiofrequency ablation for recurrent pelvic cancer.
    Lefevre JH, Parc Y, Lewin M, Bennis M, Tiret E, Parc R.
    Colorectal Dis; 2008 Oct; 10(8):781-4. PubMed ID: 18028468
    [Abstract] [Full Text] [Related]

  • 4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 5. Surgical treatment of locally recurrent rectal cancer.
    Bakx R, van Tinteren H, van Lanschot JJ, Zoetmulder FA.
    Eur J Surg Oncol; 2004 Oct 15; 30(8):857-63. PubMed ID: 15336732
    [Abstract] [Full Text] [Related]

  • 6. Outcome of total pelvic exenteration for locally recurrent rectal cancer.
    Ike H, Shimada H, Ohki S, Yamaguchi S, Ichikawa Y, Fujii S.
    Hepatogastroenterology; 2003 Oct 15; 50(51):700-3. PubMed ID: 12828064
    [Abstract] [Full Text] [Related]

  • 7. Ipsilateral ureteroureterostomy in the surgical management of the severely dilated ureter in ureteral duplication.
    Chacko JK, Koyle MA, Mingin GC, Furness PD.
    J Urol; 2007 Oct 15; 178(4 Pt 2):1689-92. PubMed ID: 17707022
    [Abstract] [Full Text] [Related]

  • 8. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer.
    Vermaas M, Ferenschild FT, Verhoef C, Nuyttens JJ, Marinelli AW, Wiggers T, Kirkels WJ, Eggermont AM, de Wilt JH.
    Eur J Surg Oncol; 2007 May 15; 33(4):452-8. PubMed ID: 17071043
    [Abstract] [Full Text] [Related]

  • 9. Renal pelvis cuff pyeloplasty for ureteropelvic junction obstruction for the high inserting ureter: an initial experience.
    Palmer LS, Proano JM, Palmer JS.
    J Urol; 2005 Sep 15; 174(3):1088-90. PubMed ID: 16094065
    [Abstract] [Full Text] [Related]

  • 10. Endourologic treatments of distal ureteral obstruction in patients with history of pelvic malignancies: efficacy and safety evaluation.
    Wen XQ, Gao X, Zhang Y, Cai YB, Qiu JG, Situ J, Zhan HL, Wang DJ.
    Ai Zheng; 2007 Nov 15; 26(11):1227-30. PubMed ID: 17991323
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
    Park JY, Seo SS, Kang S, Lee KB, Lim SY, Choi HS, Park SY.
    Gynecol Oncol; 2006 Dec 15; 103(3):977-84. PubMed ID: 16837030
    [Abstract] [Full Text] [Related]

  • 13. Hydronephrosis as a prognostic factor in pelvic recurrence from rectal and colon carcinomas.
    Larsen SG, Wiig JN, Giercksky KE.
    Am J Surg; 2005 Jul 15; 190(1):55-60. PubMed ID: 15972173
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The use of transureteroureterostomy during ureteral reconstruction for advanced primary or recurrent pelvic malignancy in the era of multimodal therapy.
    Kawamura J, Tani M, Sumida K, Yazawa T, Kawasoe J, Yamamoto M, Harada H, Yamamoto H, Zaima M.
    Int J Colorectal Dis; 2017 Jan 15; 32(1):135-138. PubMed ID: 27714520
    [Abstract] [Full Text] [Related]

  • 16. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
    Gannon CJ, Zager JS, Chang GJ, Feig BW, Wood CG, Skibber JM, Rodriguez-Bigas MA.
    Ann Surg Oncol; 2007 Jun 15; 14(6):1870-7. PubMed ID: 17406945
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The influence of type of operation for distal rectal cancer: survival, outcomes, and recurrence.
    Chiappa A, Biffi R, Zbar AP, Bertani E, Luca F, Pace U, Biella F, Grassi C, Zampino G, Fazio N, Pruneri G, Poldi D, Venturino M, Andreoni B.
    Hepatogastroenterology; 2007 Mar 15; 54(74):400-6. PubMed ID: 17523284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.